Calypso Medical Technologies, Inc. officially launched its recently FDA 510(k) cleared Calypso 4D Localization System at ASTRO, providing a new technology for real-time target localization and tumor tracking for a variety of clinical applications.
The 4D Localization System utilizes electromagnetic technology in conjunction with Calypso’s implanted Beacon Electromagnetic Transponders, in the prostate, to provide tumor location information during external beam radiation therapy without adding ionizing radiation.
Related Content
Videos | Radiation Therapy
This is Reflexion’s X1 LINAC radiotherapy system on display at ASTRO 2021. It recently gained FDA clearance for standard ...
November 11, 2021 
News | Radiation Therapy
October 30, 2018 - Displayed for the first time at American Society for Radiation Oncology (ASTRO) 2018 annual meeting ...
October 30, 2018 
Sponsored Content | Webinar | Radiation Therapy
Respiratory tumor motion often complicates the delivery of precision radiation treatment. Over the past two decades ...
August 28, 2018 
Technology | Tumor Tracking Systems
Endomag, the surgical guidance company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to ...
July 20, 2018 
News | Radiation Oncology
World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...
February 01, 2018 
Feature | Tumor Tracking Systems | By William Hall, M.D.
Radiation planning for breast cancer relies on accurate delineation of the post-lumpectomy target volume as identified on non-contrast axial computed tomography (CT). Visible seroma, surgical clips and adjacent tissue are typically included when contouring the lumpectomy clinical target volume for radiation treatment. Radiation oncologists and treatment planners face challenges that can make clear delineation of the lumpectomy cavity problematic.
November 06, 2017 
News | Radiation Therapy
El Camino Hospital (Mountain View, Calif.) announced the installation of a new Calypso 4-D Localization System and will soon be able to treat patients with certain soft tissue cancers using this precise radiation technology.
July 21, 2017 
News | Oncology Related Products
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy development paradigm, as well as his strategic vision to optimize the implementation of next-generation immunotherapies.
March 31, 2016 
Technology | Tumor Tracking Systems
Philips announced IntelliSpace Portal 8.0, the latest edition of its advanced data sharing, analytics and visualization platform that helps radiologists detect, diagnose and follow up on treatment of diseases.
December 02, 2015 
News
New research from Johns Hopkins School of Medicine reveals a high value for scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of The Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.
February 23, 2015 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now